OUR STORY
Founded in 2019 as a spin-out from the Galit Alter Lab at the Ragon Institute of Harvard, MIT, and MGH, SeromYx developed an advanced immune profiling technology to support antibody therapeutic and vaccine development. Our platform focuses on functional immune mechanisms, providing data that helps developers understand not just what antibodies bind, but how they work in the immune system.
MISSION
At SeromYx, our mission is to provide unparalleled insights into immune function through innovative profiling and advanced computational analysis. We empower the development of more effective vaccines, immunotherapies, drugs, and diagnostics by delivering actionable data that drives scientific progress.
NUMBER OF
COMPLETED PROJECTS
NUMBER OF ONGOING COLLABORATIONS
NUMBER OF
PUBLICATIONS
